Stock listing
NASDAQ:IPXL Impax Laboratories Inc Stock
Follow Impax Laboratories Inc into a list and get an email when it puts out news.
Last close · NASDAQ:IPXL
$14.71 USD
Close on May 8, 2018 · No longer trades
- Lowest – highest close
- $1.00 – $51.31 USDSince Dec 22, 1997 · lowest Oct 21, 1998 · highest Apr 15, 2015
Delisted NASDAQ:IPXL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IPXL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Impax Laboratories Inc on 6ix
- Decks
- 35 decks · latest Mar 1, 2018
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q4 2017 Earnings Presentation | Earnings | 23 slides | Mar 1, 2018 |
| J.P. Morgan Global Healthcare Conference 2018 | Conference | 19 slides | Jan 9, 2018 |
| Q3 2017 Earnings Presentation | Earnings | 22 slides | Nov 9, 2017 |
| Merger or Acquisition (October 2017) | Merger or acquisition | 22 slides | Oct 17, 2017 |
| Merger or Acquisition (October 2017) | Merger or acquisition | 43 slides | Oct 17, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 24 slides | Aug 9, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 26 slides | May 10, 2017 |
| FY2016 Earnings Presentation | Earnings | 24 slides | Mar 1, 2017 |
| 35th Annual J.P. Morgan Healthcare Conference (January 2017) | Conference | 17 slides | Jan 11, 2017 |
| Q3 2016 Earnings Presentation | Earnings | 31 slides | Nov 9, 2016 |
All 35 decks
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Paul M. Bisaro Other companies: Myriad Genetics, Inc. (Director · Since at least Oct 31, 2022); Mallinckrodt Inc (Director · Since at least Jun 16, 2022); Zoetis Inc. (Chairman of the Board · Since at least May 1, 2015); TherapeuticsMD, Inc. (Director · Mar 20, 2020 – Sep 29, 2022 · Past); Amneal Pharmaceuticals, Inc. (Executive Chairman, Director · May 4, 2018 – May 7, 2019 · Past); Zimmer Biomet Holdings, Inc. (Director · Dec 12, 2013 – Mar 31, 2017 · Past) | President and CEO, Director · Mar 27, 2017 – May 4, 2018 · Past |
| Bryan M Reasons Other companies: Mallinckrodt Inc (EVP & CFO · Since at least Mar 18, 2019); Amneal Pharmaceuticals, Inc. (CFO · May 4, 2018 – Aug 21, 2018 · Past); Aclaris Therapeutics, Inc. (Director · Apr 20, 2018 – Jun 1, 2024 · Past); Recro Pharma Inc (Director · Mar 3, 2017 – Apr 8, 2024 · Past) | Chief Financial Officer · Apr 13, 2013 – May 4, 2018 · Past |
| Douglas Boothe Other companies: Akorn Inc (President and CEO, Director · Jan 1, 2019 – Jan 8, 2020 · Past) | President, Generics Division · Aug 1, 2016 – May 4, 2018 · Past |
| Mark A Schlossberg Other companies: Cytokinetics, Incorporated (SVP - Legal & General Counsel · Jan 14, 2019 – Mar 15, 2022 · Past) | SVP and General Counsel · Feb 26, 2018 – May 4, 2018 · Past |
| Michael Nestor | President, Impax Specialty · May 20, 2010 – May 4, 2018 · Past |
| Nigel Fleming | Director · Aug 31, 2015 – Aug 31, 2015 · Past |
Log in to ask 6ix AI your own questions about Impax Laboratories Inc.